Vertex Pharmaceuticals Incorporated

VRTX · NASDAQ
Analyze with AI
$447.38−$2.14 (−0.48%)
At close:Dec 18, 2025, 9:00 PM UTC
$445.78−$1.60 (−0.36%)
After hours:Dec 19, 2025, 6:45 AM UTC
P/E TTM31.11
P/B TTM4.6
P/S TTM9.79
Dividend Yield0%
EPS$14.23
Beta0.321
Valuation
PEG Ratio23.16
FCF Yield2.91%
EV / EBITDA24.25
Quality
ROIC16.18%
Gross Margin86.28%
Cash Conv. Ratio1.01
Growth
Revenue 3Y CAGR7.26%
FCF Growth-124.10%
Safety
Net Debt / EBITDA-0.67
Interest Coverage311.98
Efficiency
Inventory Turnover0.99
Cash Conv. Cycle-485.53

Vertex Pharmaceuticals Incorporated (VRTX) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Vertex Pharmaceuticals Incorporated (VRTX) stock price today?

As of Dec 18, 2025, 9:00 PM UTC, Vertex Pharmaceuticals Incorporated (VRTX) stock is trading at $447.38. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date VRTX stock quotes for informed trading decisions.

What is Vertex Pharmaceuticals Incorporated's market capitalization?

Vertex Pharmaceuticals Incorporated (VRTX) has a market capitalization of approximately $114.8B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Vertex Pharmaceuticals Incorporated's size relative to other companies in the USD market. The market cap figure updates automatically as the VRTX stock price changes.

What is the 52-week range for Vertex Pharmaceuticals Incorporated stock?

Vertex Pharmaceuticals Incorporated (VRTX) stock has traded in a 52-week range of $362.50 — $519.68. The 52-week range shows the highest and lowest prices at which VRTX traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Vertex Pharmaceuticals Incorporated stock price to this range provides context for recent price action.

How much trading volume does Vertex Pharmaceuticals Incorporated stock have?

Vertex Pharmaceuticals Incorporated (VRTX) stock recently traded approximately 1.1M shares. Trading volume indicates market liquidity and investor interest in VRTX. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Vertex Pharmaceuticals Incorporated stock.

Does Vertex Pharmaceuticals Incorporated pay dividends to shareholders?

Yes, Vertex Pharmaceuticals Incorporated (VRTX) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Vertex Pharmaceuticals Incorporated stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Vertex Pharmaceuticals Incorporated's intraday price range?

Today, Vertex Pharmaceuticals Incorporated (VRTX) stock has traded in a range of $445.41 — $452.63. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring VRTX's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Vertex Pharmaceuticals Incorporated stock data?

AlphaPilot sources real-time VRTX stock quotes, fundamental financial data, and historical price charts for Vertex Pharmaceuticals Incorporated from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Vertex Pharmaceuticals Incorporated stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of VRTX stock performance.